Tight glycemic control in critical care - The leading role of insulin sensitivity and patient variability: A review and model-based analysis

Computer Methods and Programs in Biomedicine

Volumn 102, Issue 2, 2011, Pages 156-171

  Chase, J Geoffrey ^a   Le Compte, Aaron J ^a   Suhaimi, Fatanah ^a   Shaw, Geoffrey M ^b,c   Lynn, Adrienne ^d   Lin, Jessica ^b,c   Pretty, Christopher G ^a   Razak, Normy ^a   Parente, Jacquelyn D ^a   Hann, Christopher E ^a   Preiser, Jean Charles ^e   Desaive, Thomas ^f  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d CHRISTCHURCH WOMEN S HOSPITAL   (New Zealand)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Critical care; Glucontrol; Glycemic control; ICU; IIT; Insulin sensitivity; Intensive insulin therapy; Modeling; Mortality; SPRINT; TGC; Variability

Indexed keywords

CRITICAL CARE; GLUCONTROL; GLYCEMIC CONTROL; ICU; IIT; INSULIN SENSITIVITY; INTENSIVE INSULIN THERAPY; MODELING; MORTALITY; SPRINT; TGC; VARIABILITY;

CARBOHYDRATES; INSULIN;

INTENSIVE CARE UNITS;

ARTICLE; CLINICAL RESEARCH; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; RISK ASSESSMENT; SYSTEMATIC REVIEW; TIGHT GLYCEMIC CONTROL; VALIDATION STUDY;

ADULT; BLOOD GLUCOSE; CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INFANT, NEWBORN; INSULIN RESISTANCE; MODELS, BIOLOGICAL;

EID: 79955160950     PISSN: 01692607     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmpb.2010.11.006     Document Type: Article

References (148)

1. McCowen K.C., Malhotra A., Bistrian B.R. Stress-induced hyperglycemia. Crit. Care Clin. 2001, 17(1):107-124.
2. Capes S.E., Hunt D., Malmberg K., Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355(9206):773-778.
3. Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., Bouillon R. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 2001, 345(19):1359-1367.
4. Mizock B.A. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract. Res. Clin. Endocrinol. Metab. 2001, 15(4):533-551.
5. Thorell A., Rooyackers O., Myrenfors P., Soop M., Nygren J., Ljungqvist O.H. Intensive insulin treatment in critically ill trauma patients normalizes glucose by reducing endogenous glucose production. J. Clin. Endocrinol. Metab. 2004, 89(11):5382-5386.
6. Krinsley J.S. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin. Proc. 2003, 78(12):1471-1478.
7. Laird A.M., Miller P.R., Kilgo P.D., Meredith J.W., Chang M.C. Relationship of early hyperglycemia to mortality in trauma patients. J. Trauma 2004, 56(5):1058-1062.
8. Jeremitsky E., Omert L.A., Dunham C.M., Wilberger J., Rodriguez A. The impact of hyperglycemia on patients with severe brain injury. J. Trauma 2005, 58(1):47-50.
9. Holm C., Horbrand F., Mayr M., von Donnersmarck G.H., Muhlbauer W. Acute hyperglycaemia following thermal injury: friend or foe?. Resuscitation 2004, 60(1):71-77.
10. Branco R.G., Garcia P.C., Piva J.P., Casartelli C.H., Seibel V., Tasker R.C. Glucose level and risk of mortality in pediatric septic shock. Pediatr. Crit. Care Med. 2005, 6(4):470-472.
11. Bistrian B.R. Hyperglycemia and infection which is the chicken and which is the egg?. JPEN J. Parenter. Enteral. Nutr. 2001, 25(4):180-181.
12. Das U.N. Insulin in sepsis and septic shock. J. Assoc. Physicians India 2003, 51:695-700.
13. Marik P.E., Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004, 30(5):748-756.
14. Langouche L., Vanhorebeek I., Van den Berghe G. The role of insulin therapy in critically ill patients. Treat Endocrinol. 2005, 4(6):353-360.
15. Fernandez-Real J.M., Broch M., Richart C., Vendrell J., Lopez-Bermejo A., Ricart W. CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J. Clin. Endocrinol. Metab. 2003, 88(4):1780-1784.
16. Koch A., Gressner O.A., Sanson E., Tacke F., Trautwein C. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care. 2009, 13(3):R95.
17. Weekers F., Giulietti A.P., Michalaki M., Coopmans W., Van Herck E., Mathieu C., Van den Berghe G. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003, 144(12):5329-5338.
18. Krishnan J.A., Parce P.B., Martinez A., Diette G.B., Brower R.G. Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest 2003, 124(1):297-305.
19. Patino J.F., de Pimiento S.E., Vergara A., Savino P., Rodriguez M., Escallon J. Hypocaloric support in the critically ill. World J Surg. 1999, 23(6):553-559.
20. Weissman C. Nutrition in the intensive care unit. Crit. Care 1999, 3(5):R67-75.
21. Woolfson A.M. Control of blood glucose during nutritional support in ill patients. Intensive Care Med. 1980, 7(1):11-14.
22. Elia M., Ceriello A., Laube H., Sinclair A.J., Engfer M., Stratton R.J. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care 2005, 28(9):2267-2279.
23. der Voort P.H., Feenstra R.A., Bakker A.J., Heide L., Boerma E.C., van der Horst I.C. Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients. Clin. Endocrinol. (Oxf) 2006, 64(2):141-145.
24. Ahrens C.L., Barletta J.F., Kanji S., Tyburski J.G., Wilson R.F., Janisse J.J., Devlin J.W. Effect of low-calorie parenteral nutrition on the incidence and severity of hyperglycemia in surgical patients: a randomized, controlled trial. Crit. Care Med. 2005, 33(11):2507-2512.
25. Kim H., Son E., Kim J., Choi K., Kim C., Shin W., Suh O. Association of hyperglycemia and markers of hepatic dysfunction with dextrose infusion rates in Korean patients receiving total parenteral nutrition. Am. J. Health Syst. Pharm. 2003, 60(17):1760-1766.
26. Krajicek B.J., Kudva Y.C., Hurley H.A. Potentially important contribution of dextrose used as diluent to hyperglycemia in hospitalized patients. Diabetes Care 2005, 28(4):981-982.
27. Thorburn A., Litchfield A., Fabris S., Proietto J. Abnormal transient rise in hepatic glucose-production after oral glucose in non-insulin-dependent diabetic subjects. Diabetes Res. Clin. Pract. 1995, 28(2):127-135.
28. Larsen M.O., Rolin B., Wilken M., Carr R.D., Svendsen O. High-fat high-energy feeding impairs fasting glucose and increases fasting insulin levels in the Gottingen minipig - results from a pilot study. Lipids and Insulin Resistance: The Role of Fatty Acid Metabolism and Fuel Partitioning 2002, vol. 967:414-423. Annals of the New York Academy of Sciences, Blackwell Publishing Ltd, NY.
29. Jeschke M.G., Klein D., Herndon D.N. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann. Surg. 2004, 239(4):553-560.
30. Vanhorebeek I., Langouche L., Van den Berghe G. Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness?. Curr. Opin. Crit. Care 2005, 11(4):304-311.
31. Langouche L., Vander Perre S., Wouters P.J., D'Hoore A., Hansen T.K., Van den Berghe G. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. J. Clin. Endocrinol. Metab. 2007, 92(10):3890-3897.
32. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin. Proc. 2004, 79(8):992-1000.
33. Van den Berghe G., Wilmer A., Hermans G., Meersseman W., Wouters P.J., Milants I., Van Wijngaerden E., Bobbaers H., Bouillon R. Intensive insulin therapy in the medical ICU. N. Engl. J. Med. 2006, 354(5):449-461.
34. Chase J.G., Shaw G., Le Compte A., Lonergan T., Willacy M., Wong X.W., Lin J., Lotz T., Lee D., Hann C. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit. Care 2008, 12(2):R49.
35. Lonergan T., Compte A.L., Willacy M., Chase J.G., Shaw G.M., Hann C.E., Lotz T., Lin J., Wong X.W. A pilot study of the SPRINT protocol for tight glycemic control in critically Ill patients. Diabetes Technol. Ther. 2006, 8(4):449-462.
36. Chase J.G., Pretty C.G., Pfeifer L., Shaw G.M., Preiser J.C., Le Compte A.J., Lin J., Hewett D., Moorhead K.T., Desaive T. Organ failure and tight glycemic control in the SPRINT study. Crit. Care 2010, 14(4):R154.
37. Van den Berghe G., Wouters P.J., Kesteloot K., Hilleman D.E. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit. Care Med. 2006, 34(3):612-616.
38. Krinsley J.S., Jones R.L. Cost analysis of intensive glycemic control in critically ill adult patients. Chest 2006, 129(3):644-650.
39. Van den Berghe G., Wouters P.J., Bouillon R., Weekers F., Verwaest C., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit. Care Med. 2003, 31(2):359-366.
40. Treggiari M.M., Karir V., Yanez N.D., Weiss N.S., Daniel S., Deem S.A. Intensive insulin therapy and mortality in critically ill patients. Crit. Care 2008, 12(1):R29.
41. De La Rosa C., Donado J.H., Restrepo A.H., Quintero A.M., Gonzalez L.G., Saldarriaga N.E., Bedoya M., Toro J.M., Velasquez J.B., Valencia J.C., et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit. Care 2008, 12(5):R120.
42. Meijering S., Corstjens A.M., Tulleken J.E., Meertens J.H., Zijlstra J.G., Ligtenberg J.J. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit. Care 2006, 10(1):R19.
43. Griesdale D.E., de Souza R.J., van Dam R.M., Heyland D.K., Cook D.J., Malhotra A., Dhaliwal R., Henderson W.R., Chittock D.R., Finfer S., et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009, 35:35.
44. Brunkhorst F.M., Engel C., Bloos F., Meier-Hellmann A., Ragaller M., Weiler N., Moerer O., Gruendling M., Oppert M., Grond S., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N. Engl. J. Med. 2008, 358(2):125-139.
45. Finfer S., Chittock D.R., Su S.Y., Blair D., Foster D., Dhingra V., Bellomo R., Cook D., Dodek P., Henderson W.R., et al. Intensive versus conventional glucose control in critically ill patients. N. Engl. J. Med. 2009, 360(13):1283-1297.
46. Preiser J.C., Devos P., Ruiz-Santana S., Melot C., Annane D., Groeneveld J., Iapichino G., Leverve X., Nitenberg G., Singer P., et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the glucontrol study. Intensive Care Med. 2009, 35(10):1738-1748.
47. Henderson W.R., Finfer S. Differences in outcome between the NICE-SUGAR and Leuven trials: possible methodological explanations. Crit. Care Resusc. 2009, 11(3):175-177.
48. Myburgh J.A., Chittock D.R. Differences in outcome between the NICE-SUGAR and Leuven trials: biological mechanisms of intensive glucose control in critically ill patients. Crit. Care Resusc. 2009, 11(3):178-179.
49. Preiser J.C. NICE-SUGAR: the end of a sweet dream?. Crit. Care 2009, 13(3):143.
50. Van den Berghe G., Schetz M., Vlasselaers D., Hermans G., Wilmer A., Bouillon R., Mesotten D. Clinical review: intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target?. J. Clin. Endocrinol. Metab. 2009, 94(9):3163-3170.
51. Beardsall K., Vanhaesebrouck S., Ogilvy-Stuart A.L., Ahluwalia J.S., Vanhole C., Palmer C., Midgley P., Thompson M., Cornette L., Weissenbruch M., et al. A randomised controlled trial of early insulin therapy in very low birth weight infants, " NIRTURE" (neonatal insulin replacement therapy in Europe). BMC Pediatr. 2007, 7:29.
52. Bagshaw S.M., Webb S.A., Delaney A., George C., Pilcher D., Hart G.K., Bellomo R. Very old patients admitted to intensive care in Australia and New Zealand: a multi-centre cohort analysis. Crit. Care 2009, 13(2):R45.
53. Mesotten D. Tight glycaemic control in the intensive care unit: pitfalls in the testing of the concept. Crit. Care 2008, 12(5):187.
54. Finfer S., Delaney A. Tight glycemic control in critically ill adults. JAMA 2008, 300(8):963-965.
55. Devos P., Preiser J.C. Current controversies around tight glucose control in critically ill patients. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10(2):206-209.
56. Umpierrez G.E., Isaacs S.D., Bazargan N., You X., Thaler L.M., Kitabchi A.E. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J. Clin. Endocrinol. Metab. 2002, 87(3):978-982.
57. Jones K.W., Cain A.S., Mitchell J.H., Millar R.C., Rimmasch H.L., French T.K., Abbate S.L., Roberts C.A., Stevenson S.R., Marshall D., et al. Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery. J. Diabetes Complications 2008, 22(6):365-370.
58. Whitcomb B.W., Pradhan E.K., Pittas A.G., Roghmann M.C., Perencevich E.N. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit. Care Med. 2005, 33(12):2772-2777.
59. Badjatia N., Topcuoglu M.A., Buonanno F.S., Smith E.E., Nogueira R.G., Rordorf G.A., Carter B.S., Ogilvy C.S., Singhal A.B. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit. Care Med. 2005, 33(7):1603-1609. quiz 1623.
60. Egi M., Bellomo R., Stachowski E., French C.J., Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006, 105(2):244-252.
61. Krinsley J.S. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit. Care Med. 2008, 36(11):3008-3013.
62. Bagshaw S.M., Bellomo R., Jacka M.J., Egi M., Hart G.K., George C. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit. Care 2009, 13(3):R91.
63. Dossett L.A., Cao H., Mowery N.T., Dortch M.J., Morris J.M., May A.K. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am. Surg. 2008, 74(8):679-685. discussion 685.
64. Yu W.K., Li W.Q., Wang X.D., Yan X.W., Qi X.P., Li N., Li J.S. Influence and mechanism of a tight control of blood glucose by intensive insulin therapy on human sepsis. Zhonghua Wai Ke Za Zhi 2005, 43(1):29-32.
65. Moghissi E.S., Korytkowski M.T., DiNardo M., Einhorn D., Hellman R., Hirsch I.B., Inzucchi S.E., Ismail-Beigi F., Kirkman M.S., Umpierrez G.E. American association of clinical endocrinologists and american diabetes association consensus statement on inpatient glycemic control. Diabetes Care 2009, 32(6):1119-1131.
66. Chase J., Shaw G.M., Wong X.W., Lotz T., Lin J., Hann C.E. Model-based glycaemic control in critical care - a review of the state of the possible. Biomed. Signal Process. Control 2006, 1(1):3-21.
67. Blakemore A., Wang S., LeCompte A., Wong X., Shaw G., Lin J., Lotz T., Hann C., Chase J. Model-based insulin sensitivity as a sepsis diagnostic in critical care. J. Diabetes Sci. Technol. (JoDST) 2008, 2(3):468-477.
68. Goldberg P.A., Sakharova O.V., Barrett P.W., Falko L.N., Roussel M.G., Bak L., Blake-Holmes D., Marieb N.J., Inzucchi S.E. Improving glycemic control in the cardiothoracic intensive care unit: clinical experience in two hospital settings. J. Cardiothorac. Vasc. Anesth. 2004, 18(6):690-697.
69. Limpert E., Stahel W.A., Abbt M. Log-normal distributions across the sciences: keys and clues. Bioscience 2001, 51(5):341-352.
70. Vriesendorp T.M., DeVries J.H., van Santen S., Moeniralam H.S., de Jonge E., Roos Y.B., Schultz M.J., Rosendaal F.R., Hoekstra J.B. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit. Care Med. 2006, 34(11):2714-2718.
71. Vincent J.L., de Mendonca A., Cantraine F., Moreno R., Takala J., Suter P.M., Sprung C.L., Colardyn F., Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on " sepsis-related problems" of the European Society of Intensive Care Medicine. Crit. Care Med. 1998, 26(11):1793-1800.
72. Sakr Y., Vincent J-L., Ruokonen E., Pizzamiglio M., Installe E., Reinhart K., Moreno R. Sepsis and organ system failure are major determinants of post-intensive care unit mortality. J. Crit. Care 2008, 23(4):475-483.
73. Jones A.E., Trzeciak S., Kline J.A. The sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit. Care Med. 2009, 37(5):1649-1654.
74. Moreno R., Vincent J.L., Matos R., Mendonca A., Cantraine F., Thijs L., Takala J., Sprung C., Antonelli M., Bruining H., et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working group on sepsis related problems of the ESICM. Intensive Care Med. 1999, 25(7):686-696.
75. Finney S.J., Zekveld C., Elia A., Evans T.W. Glucose control and mortality in critically ill patients. JAMA 2003, 290(15):2041-2047.
76. Chase J.G., Hann C.E., Shaw G.M., Wong X.W., Lin J., Lotz T., Le Compte A.J., Lonergan T. An overview of glycemic control in critical care - relating performance and clinical results. J. Diabetes Sci. Technol. 2007, 1(1):82-91.
77. Wilson M., Weinreb J., Hoo G.W. Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care 2007, 30(4):1005-1011.
78. Blaha J., Hovorka R., Matias M., Kotulak T., Kremen J., Sloukova A., Svacina S., Haluzik M. Intensive insulin therapy in critically ill patients: comparison of standard and MPC protocols. Intensive Care Med. 2005, 31(S1):S203.
79. Falciglia M., Freyberg R.W., Almenoff P.L., D'Alessio D.A., Render M.L. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit. Care Med. 2009, 37(12):3001-3009.
80. Waeschle R.M., Moerer O., Hilgers R., Herrmann P., Neumann P., Quintel M. The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability. Crit. Care (London, England) 2008, 12(5):R129.
81. Braithwaite S.S., Edkins R., Macgregor K.L., Sredzienski E.S., Houston M., Zarzaur B., Rich P.B., Benedetto B., Rutherford E.J. Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions. Diabetes Technol. Ther. 2006, 8(4):476-488.
82. Natali A., Gastaldelli A., Camastra S., Sironi A.M., Toschi E., Masoni A., Ferrannini E., Mari A. Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach. Am. J. Physiol. Endocrinol. Metab. 2000, 278(5):E794-801.
83. Prigeon R.L., Roder M.E., Porte D., Kahn S.E. The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. J. Clin. Invest. 1996, 97(2):501-507.
84. Sowell M., Mukhopadhyay N., Cavazzoni P., Carlson C., Mudaliar S., Chinnapongse S., Ray A., Davis T., Breier A., Henry R.R., et al. Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp. J. Clin. Endocrinol. Metab. 2003, 88(12):5875-5880.
85. Black P.R., Brooks D.C., Bessey P.Q., Wolfe R.R., Wilmore D.W. Mechanisms of insulin resistance following injury. Ann. Surg. 1982, 196(4):420-435.
86. Lin J., Lee D.S., Chase J.G., Hann C.E., Lotz T., Wong X.W. Stochastic modelling of insulin sensitivity variability in critical care. Biomed. Signal Process. Control 2006, 1:229-242.
87. Lin J., Lee D., Chase J.G., Shaw G.M., Le Compte A., Lotz T., Wong J., Lonergan T., Hann C.E. Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care. Comput. Methods Programs Biomed. 2008, 89(2):141-152.
88. Hann C.E., Chase J.G., Lin J., Lotz T., Doran C.V., Shaw G.M. Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model. Comput. Methods Programs Biomed. 2005, 77(3):259-270.
89. Chase J.G., Shaw G.M., Lotz T., LeCompte A., Wong J., Lin J., Lonergan T., Willacy M., Hann C.E. Model-based insulin and nutrition administration for tight glycaemic control in critical care. Curr. Drug Deliv. 2007, 4(4):283-296.
90. Chase J.G., Wong X-W., Singh-Levett I., Hollingsworth L.J., Hann C.E., Shaw G.M., Lotz T., Lin J. Simulation and initial proof-of-concept validation of a glycaemic regulation algorithm in critical care. Control Eng. Pract. 2008, 16(3):271-285.
91. Lotz T.F., Chase J.G., McAuley K.A., Lee D.S., Lin J., Hann C.E., Mann J.I. Transient and steady-state euglycemic clamp validation of a model for glycemic control and insulin sensitivity testing. Diabetes Technol. Ther. 2006, 8(3):338-346.
92. Lotz T. High Resolution Clinical Model-Based Assessment of Insulin Sensitivity 2007, University of Canterbury, Christchurch.
93. Lotz T.F., Chase J.G., McAuley K.A., Shaw G.M., Wong X.W., Lin J., Lecompte A., Hann C.E., Mann J.I. Monte Carlo analysis of a new model-based method for insulin sensitivity testing. Comput. Methods Programs Biomed. 2008, 89(3):215-225.
94. Docherty P., Chase J., Lotz T., Hann C., Shaw G., Berkeley J., Mann J., McAuley K. DISTq: an iterative analysis of glucose data for low-cost, real-time and accurate estimation of insulin sensitivity. Open Med. Inform. J. 2009, 3:65-76.
95. Chase J.G., Shaw G.M., Lin J., Doran C.V., Hann C., Robertson M.B., Browne P.M., Lotz T., Wake G.C., Broughton B. Adaptive bolus-based targeted glucose regulation of hyperglycaemia in critical care. Med. Eng. Phys. 2005, 27(1):1-11.
96. Chase J.G., Shaw G.M., Lin J., Doran C.V., Hann C., Lotz T., Wake G.C., Broughton B. Targeted glycemic reduction in critical care using closed-loop control. Diabetes Technol. Ther. 2005, 7(2):274-282.
97. Wong X.W., Singh-Levett I., Hollingsworth L.J., Shaw G.M., Hann C.E., Lotz T., Lin J., Wong O.S., Chase J.G. A novel, model-based insulin and nutrition delivery controller for glycemic regulation in critically ill patients. Diabetes Technol. Ther. 2006, 8(2):174-190.
98. Wong X.W., Chase J.G., Shaw G.M., Hann C.E., Lotz T., Lin J., Singh-Levett I., Hollingsworth L.J., Wong O.S., Andreassen S. Model predictive glycaemic regulation in critical illness using insulin and nutrition input: a pilot study. Med. Eng. Phys. 2006, 28(7):665-681.
99. Lonergan T., LeCompte A., Willacy M., Chase J.G., Shaw G.M., Wong X.W., Lotz T., Lin J., Hann C.E. A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. Diabetes Technol. Ther. 2006, 8(2):191-206.
100. Le Compte A., Chase J., Lynn A., Hann C., Shaw G., Wong X., Lin J. Blood glucose controller for neonatal intensive care: virtual trials development and 1st clinical trials. J. Diabetes Sci. Technol. (JoDST) 2009, 3(5):1066-1081.
101. Chase J.G., Andreassen S., Pielmeier U., Hann C.E., McAuley K.A., Mann J.I. A glucose-insulin pharmacodynamic surface modeling validation and comparison of metabolic system models. Biomed. Signal Process. Control 2009, 4(4):355-363.
102. Wong J., Chase J.G., Hann C.E., Lotz T.F., Lin J., Le Compte A., Shaw G.M. Development of a clinical type 1 diabetes metabolic system model and in silico simulation tool. J. Diabetes Sci. Technol. 2008, 2(3):425-435.
103. Wong J., Chase J.G., Hann C.E., Lotz T.F., Lin J., Le Compte A., Shaw G.M. In silico simulation of long-term type 1 diabetes glycemic control treatment outcomes. J. Diabetes Sci. Technol. 2008, 2(3):425-435.
104. Wong X., Chase J., LeCompte A., Hann C., Lin J., Shaw G. An adaptive clinical Type 1 diabetes control protocol to optimise conventional self-monitoring blood glucose and multiple daily injection therapy. Intl. J. Adapt. Signal Process. Control (IJACSP) 2009, 23(5):408-434.
105. LeCompte A., Chase J., Lynn A., Hann C., Shaw G., Wong X., Lin J. Blood glucose controller for neonatal intensive care: virtual trials development and 1st clinical trials. J. Diabetes Sci. Technol. (JoDST) 2009, 3(5):1066-1081.
106. Le Compte A.J., Lee D.S., Chase J.G., Lin J., Lynn A., Shaw G.M. Blood glucose prediction using stochastic modeling in neonatal intensive care. IEEE Trans. Biomed. Eng. 2010, 57(3):509-518.
107. Suhaimi F., Le Compte A., Preiser J.C., Shaw G.M., Massion P., Radermecker R., Pretty C., Lin J., Desaive T., Chase J.G. What makes tight glycemic control (TGC) tight? The impact of variability and nutrition in 2 clinical studies. J. Diabetes Sci. Technol. 2010, 4(2):284-298.
108. Plank J., Blaha J., Cordingley J., Wilinska M.E., Chassin L.J., Morgan C., Squire S., Haluzik M., Kremen J., Svacina S., et al. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care 2006, 29(2):271-276.
109. Goldberg P.A., Siegel M.D., Sherwin R.S., Halickman J.I., Lee M., Bailey V.A., Lee S.L., Dziura J.D., Inzucchi S.E. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004, 27(2):461-467.
110. Inzucchi S.E. Clinical practice Management of hyperglycemia in the hospital setting. N. Engl. J. Med. 2006, 355(18):1903-1911.
111. Thomas A.N., Marchant A.E., Ogden M.C., Collin S. Implementation of a tight glycaemic control protocol using a web-based insulin dose calculator. Anaesthesia 2005, 60(11):1093-1100.
112. Waeschle R., Moerer O., Wahaha D., Neumann P., Quintel M. Intensive insulin therapy on ICU: comparison of two algorithms to control the blood glucose level. Intensive Care Med. 2005, 31(S1):S203.
113. Vogelzang M., Zijlstra F., Nijsten M.W. Design and implementation of GRIP: a computerized glucose control system at a surgical intensive care unit. BMC Med. Inform. Decis. Mak. 2005, 5(38):10.
114. Chee F., Fernando T., van Heerden P.V. Closed-loop control of blood glucose levels in critically ill patients. Anaesth. Intensive Care 2002, 30(3):295-307.
115. Chee F., Fernando T.L., Savkin A.V., van Heeden V. Expert PID control system for blood glucose control in critically ill patients. IEEE Trans. Inf. Technol. Biomed. 2003, 7(4):419-425.
116. Juneja R., Roudebush C., Kumar N., Macy A., Golas A., Wall D., Wolverton C., Nelson D., Carroll J., Flanders S.J. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol. Ther. 2007, 9(3):232-240.
117. Davidson P.C., Steed R.D., Bode B.W. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care 2005, 28(10):2418-2423.
118. Krinsley J. Perioperative glucose control. Curr. Opin. Anaesthesiol. 2006, 19(2):111-116.
119. Beardsall K., Vanhaesebrouck S., Ogilvy-Stuart A.L., Vanhole C., Palmer C.R., van Weissenbruch M., Midgley P., Thompson M., Thio M., Cornette L., et al. Early insulin therapy in very-low-birth-weight infants. N. Engl. J. Med. 2008, 359(18):1873-1884.
120. LeCompte A., Chase J., Shaw G., Lynn A., Russell G. Blood glucose modelling and control for pre-term infants. 2008 Engineering & Physical Sciences in Medicine and Australian Biomedical Engineering Conference (EPSM ABEC 2008) 2008, ABEC, Christchurch, New Zealand.
121. Elia M., De Silva A. Tight glucose control in intensive care units: an update with an emphasis on nutritional issues. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11(4):465-470.
122. Iapichino G., Rossi C., Radrizzani D., Simini B., Albicini M., Ferla L., Bassi G., Bertolini G. Nutrition given to critically ill patients during high level/complex care (on Italian ICUs). Clin. Nutr. 2004, 23(3):409-416.
123. Jones N.E., Dhaliwal R., Day A.G., Jiang X., Heyland D.K. Nutrition therapy in the critical care setting: what is " best achievable" practice? An international multicenter observational study. Crit. Care Med. 2009.
124. Vriesendorp T.M., van Santen S., DeVries J.H., de Jonge E., Rosendaal F.R., Schultz M.J., Hoekstra J.B. Predisposing factors for hypoglycemia in the intensive care unit. Crit. Care Med. 2006, 34(1):96-101.
125. Chase J., Andreassen S., Jensen K., Shaw G. The impact of human factors on clinical protocol performance - a proposed assessment framework and case examples. J. Diabetes Sci. Technol. (JoDST) 2008, 2(3):409-416.
126. Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am. J. Crit. Care 2006, 15(4):370-377.
127. Mackenzie I., Ingle S., Zaidi S., Buczaski S. Tight glycaemic control: a survey of intensive care practice in large English hospitals. Intensive Care Med. 2005, 31(8):1136.
128. Schultz M.J., Spronk P.E., Moeniralam H.S. Tight glycaemic control: a survey of intensive care practice in the Netherlands. Intensive Care Med. 2006, 32(4):618-619.
129. Sauer P., Van Horn E.R. Impact of intravenous insulin protocols on hypoglycemia, patient safety, and nursing workload. Dimens. Crit. Care Nurs. 2009, 28(3):95-101.
130. Schultz M.J., de Graaff M.J., Royakkers A.A., van Braam Houckgeest F., van der Sluijs J.P., Kieft H., Spronk P.E. Practice of strict glycemic control in critically ill patients. Med. Sci. Monit. 2008, 14(11):RA191-197.
131. Wilinska M.E., Chassin L.J., Hovorka R. Automated glucose control in the ICU: effect of nutritional protocol and measurement error. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2006, 1:67-70.
132. Shulman R., Finney S.J., O'Sullivan C., Glynne P.A., Greene R. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol. Crit. Care 2007, 11(4):R75.
133. Mann E.A., Mora A.G., Pidcoke H.F., Wolf S.E., Wade C.E. Glycemic control in the burn intensive care unit: focus on the role of anemia in glucose measurement. J. Diabetes Sci. Technol. (Online) 2009, 3(6):1319-1329.
134. Ray J.G., Hamielec C., Mastracci T. Pilot study of the accuracy of bedside glucometry in the intensive care unit. Crit. Care Med. 2001, 29(11):2205-2207.
135. Jacobs B., Phan K., Bertheau L., Dogbey G., Schwartz F., Shubrook J. Continuous glucose monitoring system in a rural intensive care unit: a pilot study evaluating accuracy and acceptance. J. Diabetes Sci. Technol. (Online) 2010, 4(3):636-644.
136. Goldberg P.A., Siegel M.D., Russell R.R., Sherwin R.S., Halickman J.I., Cooper D.A., Dziura J.D., Inzucchi S.E. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol. Ther. 2004, 6(3):339-347.
137. Holzinger U., Warszawska J., Kitzberger R., Wewalka M., Miehsler W., Herkner H., Madl C. Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care 2010, 33(3):467-472.
138. Harris D.L., Battin M.R., Williams C.E., Weston P.J., Harding J.E. Cot-side electro-encephalography and interstitial glucose monitoring during insulin-induced hypoglycaemia in newborn lambs. Neonatology 2009, 95(4):271-278.
139. Javid P.J., Halwick D.R., Betit P., Thompson J.E., Long K., Zhang Y., Jaksic T., Agus M.S. The first use of live continuous glucose monitoring in patients on extracorporeal life support. Diabetes Technol. Ther. 2005, 7(3):431-439.
140. Chee F., Fernando T., van Heerden P.V. Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. IEEE Trans. Inf. Technol. Biomed. 2003, 7(1):43-53.
141. De Block C., Manuel Y.K.B., Van Gaal L., Rogiers P. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care 2006, 29(8):1750-1756.
142. Bequette B.W. Continuous glucose monitoring: real-time algorithms for calibration, filtering, and alarms. J. Diabetes Sci. Technol. (Online) 2010, 4(2):404-418.
143. Pretty C.G., Chase J.G., Le Compte A., Shaw G.M., Signal M. Hypoglycemia detection in critical care using continuous glucose monitors: an in silico proof of concept analysis. J. Diabetes Sci. Technol. (Online) 2010, 4(1):15-24.
144. Signal M., Pretty C.G., Chase J.G., Le Compte A., Shaw G.M. Continuous glucose monitors and the burden of tight glycemic control in critical care: can they cure the time cost?. J. Diabetes Sci. Technol. (Online) 2010, 4(3):625-635.
145. Bode B., Gross K., Rikalo N., Schwartz S., Wahl T., Page C., Gross T., Mastrototaro J. Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol. Ther. 2004, 6(2):105-113.
146. Van den Berghe G., Wilmer A., Milants I., Wouters P.J., Bouckaert B., Bruyninckx F., Bouillon R., Schetz M. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006, 55(11):3151-3159.
147. Preiser J.C., Devos P., Chiolero R. Which factors influence glycemic control in the intensive care unit?. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13(2):205-210.
148. Lacherade J.C., Jacqueminet S., Preiser J.C. An overview of hypoglycemia in the critically ill. J. Diabetes Sci. Technol. (Online) 2009, 3(6):1242-1249.